Financial News

Provectus Algae Closes Series A Extension as Breakthrough Programs Move Toward Commercial Scale

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

US$4.3 million extension brings total Series A funding to more than US$14 million, following significant commercial and technical milestones across animal agriculture, human nutraceuticals and crop protection

Provectus Algae, the Australian biotechnology company using advanced biomanufacturing to develop next-generation biological products, has closed a US$4.3 million extension to its Series A financing, bringing total Series A funding to more than US$14 million.

The Series A was led by At One Ventures, with the extension welcoming Queensland Investment Corporation (QIC) as a new investor, including through the Queensland Government’s A$30 million Sowing the Seeds of Farming Innovation Fund, managed by QIC, alongside continued support from existing shareholders.

The additional investment follows a period of significant technical and commercial progress for Provectus Algae, with programs developed through its Precision Photosynthesis® and AI-enabled discovery and biomanufacturing platform advancing from development toward commercialisation.

Leading that transition is Surf’N’Turf®, Provectus Algae’s methane-reducing cattle feed technology, which is now being commercialised through Proteus Ag.

Commercial pilots with major lot-feeding company Mort & Co involving more than 2,700 cattle demonstrated a 67% reduction in methane measured in expired air, with no detectable residue and no withholding period. Developed to perform in the harsh Australian environment Surf’N’Turf® has now proven performance in existing commercial feeding systems.

Following those results, Proteus Ag is progressing the commercial rollout of Surf’N’Turf® to Australian cattle producers, while manufacturing capacity in Queensland is being scaled to support supply of 250,000 cattle in 2027.

The company is simultaneously advancing programs in human nutraceuticals and crop-protection biologics, creating additional commercial pathways from the same underlying discovery and biomanufacturing platform.

The Series A extension will provide capital to accelerate those programs while enabling Proteus Ag to build the manufacturing, commercial and supply capabilities required for the next phase of Surf’N’Turf®.

“Over the last few years we have been building the technology platform, infrastructure and team required to turn biology into commercially relevant products. We are now seeing the results of that investment,” said Nusqe Spanton, Founder and CEO of Provectus Algae.

“Surf’N’Turf® has moved from something we believed could work into a product demonstrating meaningful results in thousands of animals under commercial conditions. We are now building the capability to supply it at scale through Proteus Ag.

“At the same time, other programs emerging from our platform are moving toward commercial opportunities in markets including human nutraceuticals and crop protection. That is important because it demonstrates that what we have built is much bigger than a single product.

“This extension gives us the capital to accelerate that transition. The next phase for Provectus is increasingly about converting the science and infrastructure we have built into products, customers and revenue.”

“We backed Provectus seeing the potential for a major win for both the cattle industry and the environment. Surf’N’Turf® is now a product ready to scale into that vision. It has been tested with commercial operators with thousands of cattle, in a product that fits into the systems producers already run, which simplifies adoption. Provectus also has nutraceutical and crop-protection programs now burgeoning from the same platform, all of which we see as compelling expansion options for the business.”

Tom Chi, Founding and Managing Partner, At One Ventures

“Provectus is tackling a challenge that matters to cattle producers everywhere, showing that emissions reduction can go hand-in-hand with better producer returns,” said Nicholas Guest, QIC Private Equity Partner.

“If Provectus can consistently pair methane reductions with improved feed efficiency, it would give producers a direct incentive to adopt the technology and provide a pathway into a global cattle market of around 1.5 billion head.

“For the Sowing the Seeds of Farming Innovation Fund, Provectus brings together technology developed and manufactured in Queensland, a clear application to one of the state's most important primary industries, and the potential to build a globally relevant business from that foundation.”

The extension represents the next stage in a journey that began with Provectus Algae developing an integrated platform capable of discovering, optimising and manufacturing biological products.

Its proprietary Precision Photosynthesis® technology combines controlled biological systems with AI-enabled discovery and biomanufacturing capabilities, allowing the company to identify target biological activity and develop production processes designed for commercial scale.

The company’s original Series A was raised to expand production of Surf’N’Turf®, undertake large-scale commercial trials and accelerate the broader platform. Those investments have helped move Surf’N’Turf® from development into commercialisation and have supported the emergence of additional programs from the Provectus pipeline.

With Proteus Ag now focused on taking Surf’N’Turf® to market, Provectus Algae will continue developing and commercialising new biological products from its platform, with current programs spanning agriculture, crop protection and human health.

ABOUT PROVECTUS ALGAE

Provectus Algae is an Australian biosolutions company developing and commercialising biological products.

Through its proprietary Precision Photosynthesis® and AI-enabled discovery and biomanufacturing technologies, Provectus Algae has built an integrated platform capable of taking new biosolutions from discovery through development, scale-up and commercial production.

The company is developing a pipeline of products across animal agriculture, crop protection, human nutraceuticals and other high-value biological markets.

Provectus Algae is headquartered in Noosaville, Queensland, Australia.

To learn more, visit provectusalgae.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  256.61
-1.14 (-0.44%)
AAPL  350.97
-1.81 (-0.51%)
AMD  488.77
-15.51 (-3.08%)
BAC  49.33
-0.75 (-1.51%)
GOOG  277.21
-4.05 (-1.44%)
META  619.80
-6.61 (-1.06%)
MSFT  506.13
-11.86 (-2.29%)
NVDA  152.70
-3.44 (-2.20%)
ORCL  114.36
-4.73 (-3.98%)
TSLA  379.53
-0.21 (-0.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback